ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial.

Tadaaki Nishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.